24GUT540 : Meeting of Breast Cancer Patients and Pathologists
Historically, most pathologists have had little direct contact or communication with patients. In the past two decades, however, there has been a modest movement toward patient-pathologist visits in which pathologists review with patients their pathology slides. Very few studies of such encounters have been conducted.
| Condition(s) | Breast Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Historically, most pathologists have had little direct contact or communication with patients. In the past two decades, however, there has been a modest movement toward patient-pathologist visits in which pathologists review with patients their pathology slides. Very few studies of such encounters have been conducted. Most surveyed patients reported that the experience was positive and helpful to them. Our basic goal is to determine if such meetings are useful to patients; a secondary goal is to determine if such encounters are useful to, and practical for, pathologists. |
| Who can participate | Inclusion Criteria: 1. Must be at least 18 years of age. 2. Patients must have completed initial diagnosis visit with oncologist or surgeon. 3. Must have pathology slides and reports available for review. 4. Must be able to speak English. 5. Must be willing to participate in this research and will be provided with an information sheet. 6. Pregnant women are eligible as this research poses no risk of physical harm to the participant. Exclusion Criteria: 1. Patients \<18 years of age. 2. Patients with DCIS are ineligible. 3. Adults who are unable to provide written signature. 4. Patients from vulnerable patient populations, including infants, minors, those unable to provide informed consent, and those incarcerated or imprisoned at the time of enrollment. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Dartmouth-Hitchcock Medical Center |
| Locations | Lebanon, New Hampshire, United States |
| Start date | 2025-07-10 |
| NCT ID | NCT07040514 |
| Official listing | https://clinicaltrials.gov/study/NCT07040514 |